Evicenter

Trodelvy (sacituzumab govitecan-hziy) in Metastatic triple-negative breast cancer

Manufacturer
Gilead Sciences, Inc.
Prescribing information
Trodelvy (opens in a new tab)
Questions
47
Last updated

All products

47 questions · 15 sources

Indication2 questions · 2 sources

Pharmacology4 questions · 2 sources

Clinical trials7 questions · 5 sources

Real-world evidence2 questions · 1 source

Safety12 questions · 4 sources

Specific populations2 questions · 1 source

Drug interactions1 question · 2 sources

Dosing and administration9 questions · 6 sources

Access and coverage7 questions · 3 sources

Guidelines1 question · 2 sources